Investors & Media
What's new.
Press releases
Press releases.
January 4th 2023
press releases
December 23rd 2022
press releases
Investor updates
Investor updates.
Analyst reports
Analyst reports.
Bell Potter - Immutep (IMM): Manufacturing process established for IMP761 (autoimmune disease targeting antibody) (Analyst: Dr Tara Speranza)
December 6th 2022
analyst reports